L731-0216 Screening compound: N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-1,3-thiazolidine-4-carboxamide

L731-0216 Screening compound: N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-1,3-thiazolidine-4-carboxamide
L731-0216 Screening compound: N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-1,3-thiazolidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L731-0216
N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-1,3-thiazolidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L731-0216

Molecular Formula

C24H25N3O2S2 (C24 H25 N3 O2 S2)

Compound Name

N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-1,3-thiazolidine-4-carboxamide

IUPAC name

(4S)-N-[2-(2-phenyl-13-thiazol-4-yl)ethyl]-3-(3-phenylpropanoyl)-13-thiazolidine-4-carboxamide

SMILES

O=C(CCc1ccccc1)N(CSC1)[C@H]1C(NCCc1csc(-c2ccccc2)n1)=O

InChI

InChI=1S/C24H25N3O2S2/c28-22(12-11-18-7-3-1-4-8-18)27-17-30-16-21(27)23(29)25-14-13-20-15-31-24(26-20)19-9-5-2-6-10-19/h1-10,15,21H,11-14,16-17H2,(H,25,29)/t21-/m1/s1

InChI Key

LNDFFDWOOATEEN-OAQYLSRUSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.463

Distribution Coefficient, logD

4.463

Water Solubility, LogSw

-4.47

Polar Surface Area

50.891

Acid Dissociation Constant (pKa)

14.49

Base Dissociation Constant (pKb)

1.76

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.20

L731-0216 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L731-0216 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L731-0216?
Check Price and Availability of L731-0216, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L731-0216 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L731-0216
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L731-0216
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L731-0216 available by request